Centile Bioscience Inc., 2026-04-16
An SEC Form D private-offering notice from Bethesda, MD, a $4,054,996 filer-stated offering target in Biotech. Filed 2026-04-16. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops CentileOS, a software platform that turns brain imaging data into standardized, population referenced biomarkers for neuroscience research and CNS drug development
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- CFrame, Inc., 2026-04-29, Frederick, MD
- Aethl Bio, Inc., 2026-04-17, $5M, Pittsburgh, PA
- Novel Microdevices, Inc., 2026-04-27, $8M, Baltimore, MD
- Bonum Therapeutics, Inc., 2026-04-17, $32.3M, Seattle, WA
- Pearl Diagnostics, Inc., 2026-04-21, $11.2M, Baltimore, MD
- InverseBio Inc., 2026-04-16, $600K, Cambridge, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.